Make Way For More Tech Investment: Index Ventures Raises Another €350M Fund
The economic signals coming from Europe are leading some to predict a big drop in startup investments up ahead, but that's not the message coming from one of the region's biggest VC firms.
Context & Ripple Effects
Index Ventures has closed another €350M fund at a moment when economic signals out of Europe are leading some observers to predict a sharp drop in startup investment ahead — a prediction the firm's raise directly contradicts. The story travelled unusually widely for a fund-size announcement: TechCrunch, GigaOM, CNET, AllThingsD, VentureBeat, Fortune and others all carried it on or about June 17, 2012, which says more about the contrarian timing than the number itself.
For a region whose venture market has historically been thinner than the US, a single firm banking €350M of dry powder mid-crisis is a statement about where European deal flow will concentrate if the predicted downturn materializes.
First-order effects
- European founders raising seed and early-stage rounds now have a freshly capitalized €350M backer at exactly the moment macro signals are pushing other investors toward caution.
- Index's limited partners are making an explicit countercyclical bet: committing new capital against a widely voiced forecast of declining European startup investment.
Second-order effects
- Rival European VC firms come under pressure to demonstrate comparable dry powder, since founders will favor the best-capitalized term sheets if funding conditions tighten.
- If the predicted investment drop arrives, pricing power in competitive European deals shifts further toward the few firms with fresh funds rather than the broader investor base.
Third-order effects
- A repeated pattern of large firms raising through downturns while smaller funds pause points toward consolidation of European venture capital around a handful of scaled pools, raising the bar for new entrants.
- Whether Europe's late-stage funding gap narrows or widens depends on whether these larger funds deploy across stages or stay concentrated at early stage — the corpus gives no basis yet to call that direction.
The trend: European venture capital is testing whether established firms can raise larger, countercyclical funds even as macro conditions push overall startup investment down.